Ramon Alemany Selected Research

Ganciclovir (Cytovene)

1/2013	Intraductal delivery of adenoviruses targets pancreatic tumors in transgenic Ela-myc mice and orthotopic xenografts.
1/2011	Oncolytic adenoviruses armed with thymidine kinase can be traced by PET imaging and show potent antitumoural effects by ganciclovir dosing.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ramon Alemany Research Topics

Disease

56	Neoplasms (Cancer) 03/2022 - 03/2002
10	Glioma (Gliomas) 10/2009 - 10/2002
9	Infections 06/2021 - 03/2002
6	Pancreatic Neoplasms (Pancreatic Cancer) 01/2019 - 06/2009
5	Melanoma (Melanoma, Malignant) 03/2022 - 08/2002
4	Neoplasm Metastasis (Metastasis) 01/2019 - 06/2009
4	Retinoblastoma (Glioblastoma, Retinal) 01/2019 - 05/2003
3	Adenocarcinoma 01/2022 - 01/2019
3	Brain Neoplasms (Brain Tumor) 01/2015 - 03/2004
2	Inflammation (Inflammations) 03/2022 - 07/2003
2	Thrombocytopenia (Thrombopenia) 01/2022 - 09/2012
2	Glioblastoma (Glioblastoma Multiforme) 01/2021 - 10/2002
2	Bites and Stings (Sting) 01/2018 - 01/2017
1	Enterocolitis 01/2022
1	Febrile Neutropenia 01/2022
1	Virus Diseases (Viral Diseases) 01/2019
1	Ovarian Neoplasms (Ovarian Cancer) 10/2018
1	Mesothelioma 10/2018
1	Leukemia 01/2018
1	Lymphoma (Lymphomas) 01/2018
1	Hematologic Neoplasms (Hematological Malignancy) 01/2018
1	Coinfection 09/2015
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2015
1	Communicable Diseases (Infectious Diseases) 04/2014
1	Wounds and Injuries (Trauma) 11/2013
1	Carcinoma (Carcinomatosis) 09/2012
1	Fatigue 06/2010
1	Hyponatremia 06/2010
1	Fever (Fevers) 06/2010
1	Chills 06/2010
1	Colonic Neoplasms (Colon Cancer) 07/2009

Drug/Important Bio-Agent (IBA)

12	Proteins (Proteins, Gene)FDA Link 01/2019 - 07/2003
8	Hyaluronoglucosaminidase (Hyaluronidase)FDA Link 01/2022 - 07/2010
7	IntegrinsIBA 03/2015 - 03/2002
5	AntigensIBA 10/2018 - 01/2004
4	CytokinesIBA 03/2022 - 09/2012
4	Peptides (Polypeptides)IBA 01/2021 - 09/2007
3	Gemcitabine FDA Link 01/2022 - 04/2017
3	AntibodiesIBA 11/2021 - 01/2017
3	Antineoplastic Agents (Antineoplastics)IBA 11/2021 - 04/2004
3	Hyaluronic Acid (Hyaluronan)IBA 01/2021 - 07/2010
3	Thymidine KinaseIBA 01/2013 - 07/2009
2	Immune Checkpoint InhibitorsIBA 03/2022 - 01/2021
2	ChemokinesIBA 03/2022 - 10/2017
2	InterferonsIBA 03/2022 - 10/2018
2	Biological ProductsIBA 01/2022 - 05/2014
2	130-nm albumin-bound paclitaxelIBA 01/2022 - 04/2017
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2022 - 09/2012
2	Pharmaceutical PreparationsIBA 11/2021 - 01/2014
2	LigandsIBA 01/2021 - 10/2009
2	Neoplasm Antigens (Tumor Antigens)IBA 01/2021 - 01/2014
2	Collagen Type I (Type I Collagen)IBA 01/2019 - 10/2017
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2019 - 10/2018
2	Chimeric Antigen ReceptorsIBA 01/2018 - 01/2018
2	Antiviral Agents (Antivirals)IBA 01/2017 - 01/2012
2	Therapeutic UsesIBA 02/2014 - 10/2002
2	Ganciclovir (Cytovene)FDA LinkGeneric 01/2013 - 01/2011
2	Verapamil (Calan)FDA LinkGeneric 01/2012 - 05/2010
2	arginyl-glycyl-aspartic acidIBA 10/2009 - 10/2002
2	adenovirus receptorIBA 12/2008 - 05/2003
2	Retinoblastoma ProteinIBA 09/2007 - 05/2003
2	adenovirus associated RNA (VA RNA)IBA 09/2006 - 09/2003
2	Messenger RNA (mRNA)IBA 09/2006 - 07/2003
2	Coxsackie and Adenovirus Receptor-Like Membrane ProteinIBA 10/2002 - 03/2002
1	Interleukin-27 (Interleukin 27)IBA 03/2022
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2022
1	Codon (Codons)IBA 06/2021
1	Viral AntigensIBA 01/2021
1	Interleukin-6 (Interleukin 6)IBA 01/2019
1	Toll-Like Receptor 9IBA 01/2019
1	MicroRNAs (MicroRNA)IBA 01/2019
1	B7-H1 AntigenIBA 10/2018
1	EnzymesIBA 10/2018
1	MesothelinIBA 10/2018
1	Arginine (L-Arginine)FDA Link 03/2018
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 03/2018
1	Folate Receptor 1IBA 01/2018
1	Neutralizing AntibodiesIBA 10/2016
1	Heparitin Sulfate (Heparan Sulfate)IBA 03/2015
1	GlycosaminoglycansIBA 03/2015
1	Metalloproteases (Metalloproteinases)IBA 10/2014
1	Matrix Metalloproteinases (MMPs)IBA 10/2014
1	dl1520 (ONYX-015)IBA 10/2014
1	VaccinesIBA 04/2014
1	Alanine Transaminase (SGPT)IBA 09/2012
1	Complementary DNA (cDNA)IBA 07/2010
1	Transaminases (Aminotransferases)IBA 06/2010
1	Docetaxel (Taxotere)FDA Link 11/2009
1	Heparin (Liquaemin)FDA LinkGeneric 10/2009
1	Sulfates (Sulfates, Inorganic)IBA 10/2009
1	Heparan Sulfate Proteoglycans (Heparan Sulfate Proteoglycan)IBA 10/2009
1	Tetrahydrofolate Dehydrogenase (Dihydrofolate Reductase)IBA 07/2009

Therapy/Procedure

23	Therapeutics 03/2022 - 10/2002
6	Oncolytic Virotherapy 10/2021 - 09/2003
6	Immunotherapy 09/2021 - 01/2018
4	Drug Therapy (Chemotherapy) 01/2022 - 10/2009
4	Intravenous Administration 10/2021 - 01/2013
4	Injections 01/2019 - 10/2002
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2018
1	Long-Term Care 11/2013